Literature DB >> 21246320

Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals.

Scott L Letendre1, Jialin C Zheng, Marcus Kaul, Constantin T Yiannoutsos, Ronald J Ellis, Michael J Taylor, Jennifer Marquie-Beck, Bradford Navia.   

Abstract

Chemokines influence HIV neuropathogenesis by affecting the HIV life cycle, trafficking of macrophages into the nervous system, glial activation, and neuronal signaling and repair processes; however, knowledge of their relationship to in vivo measures of cerebral injury is limited. The primary objective of this study was to determine the relationship between a panel of chemokines in cerebrospinal fluid (CSF) and cerebral metabolites measured by proton magnetic resonance spectroscopy (MRS) in a cohort of HIV-infected individuals. One hundred seventy-one stored CSF specimens were assayed from HIV-infected individuals who were enrolled in two ACTG studies that evaluated the relationship between neuropsychological performance and cerebral metabolites. Concentrations of six chemokines (fractalkine, IL-8, IP-10, MCP-1, MIP-1β, and SDF-1) were measured and compared with cerebral metabolites individually and as composite neuronal, basal ganglia, and inflammatory patterns. IP-10 and MCP-1 were the chemokines most strongly associated with individual cerebral metabolites. Specifically, (1) higher IP-10 levels correlated with lower N-acetyl aspartate (NAA)/creatine (Cr) ratios in the frontal white matter and higher MI/Cr ratios in all three brain regions considered and (2) higher MCP-1 levels correlated with lower NAA/Cr ratios in frontal white matter and the parietal cortex. IP-10, MCP-1, and IL-8 had the strongest associations with patterns of cerebral metabolites. In particular, higher levels of IP-10 correlated with lower neuronal pattern scores and higher basal ganglia and inflammatory pattern scores, the same pattern which has been associated with HIV-associated neurocognitive disorders (HAND). Subgroup analysis indicated that the effects of IP-10 and IL-8 were influenced by effective antiretroviral therapy and that memantine treatment may mitigate the neuronal effects of IP-10. This study supports the role of chemokines in HAND and the validity of MRS as an assessment tool. In particular, the findings identify relationships between the immune response-particularly an interferon-inducible chemokine, IP-10-and cerebral metabolites and suggest that antiretroviral therapy and memantine modify the impact of the immune response on neurons.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21246320      PMCID: PMC3032187          DOI: 10.1007/s13365-010-0013-2

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  35 in total

1.  Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro.

Authors:  V C Asensio; J Maier; R Milner; K Boztug; C Kincaid; M Moulard; C Phillipson; K Lindsley; T Krucker; H S Fox; I L Campbell
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

Review 2.  HIV-1 infection and AIDS: consequences for the central nervous system.

Authors:  M Kaul; J Zheng; S Okamoto; H E Gendelman; S A Lipton
Journal:  Cell Death Differ       Date:  2005-08       Impact factor: 15.828

Review 3.  Chemokines and their receptors in the central nervous system.

Authors:  A Bajetto; R Bonavia; S Barbero; T Florio; G Schettini
Journal:  Front Neuroendocrinol       Date:  2001-07       Impact factor: 8.606

4.  Astrocytes, not microglia, are the main cells responsible for viral persistence in Theiler's murine encephalomyelitis virus infection leading to demyelination.

Authors:  L Zheng; M A Calenoff; M C Dal Canto
Journal:  J Neuroimmunol       Date:  2001-08-30       Impact factor: 3.478

5.  Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis.

Authors:  M C Zink; G D Coleman; J L Mankowski; R J Adams; P M Tarwater; K Fox; J E Clements
Journal:  J Infect Dis       Date:  2001-09-10       Impact factor: 5.226

6.  Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes.

Authors:  O Kutsch; J Oh; A Nath; E N Benveniste
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

7.  HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels.

Authors:  Enrique Gonzalez; Brad H Rovin; Luisa Sen; Glen Cooke; Rahul Dhanda; Srinivas Mummidi; Hemant Kulkarni; Michael J Bamshad; Vanessa Telles; Stephanie A Anderson; Elizabeth A Walter; Kevin T Stephan; Michael Deucher; Andrea Mangano; Rosa Bologna; Seema S Ahuja; Matthew J Dolan; Sunil K Ahuja
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-08       Impact factor: 11.205

8.  The C-X-C chemokine IP-10 stimulates HIV-1 replication.

Authors:  Brian R Lane; Steven R King; Paul J Bock; Robert M Strieter; Michael J Coffey; David M Markovitz
Journal:  Virology       Date:  2003-03-01       Impact factor: 3.616

9.  Neuronal injury regulates fractalkine: relevance for HIV-1 associated dementia.

Authors:  David Erichsen; Alicia L Lopez; Hui Peng; Douglas Niemann; Clancy Williams; Michael Bauer; Susan Morgello; Robin L Cotter; Lisa A Ryan; Anuja Ghorpade; Howard E Gendelman; Jialin Zheng
Journal:  J Neuroimmunol       Date:  2003-05       Impact factor: 3.478

10.  Neutralization of IFN-inducible protein 10/CXCL10 exacerbates experimental autoimmune encephalomyelitis.

Authors:  Shosaku Narumi; Toshikatu Kaburaki; Hiroyuki Yoneyama; Hiroyuki Iwamura; Yuko Kobayashi; Kouji Matsushima
Journal:  Eur J Immunol       Date:  2002-06       Impact factor: 5.532

View more
  57 in total

1.  Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium.

Authors:  Yuri Persidsky; Shongshan Fan; Holly Dykstra; Nancy L Reichenbach; Slava Rom; Servio H Ramirez
Journal:  J Neuroimmune Pharmacol       Date:  2015-02-11       Impact factor: 4.147

2.  A peripheral monocyte interferon phenotype in HIV infection correlates with a decrease in magnetic resonance spectroscopy metabolite concentrations.

Authors:  Lynn Pulliam; Hans Rempel; Bing Sun; Linda Abadjian; Cyrus Calosing; Dieter J Meyerhoff
Journal:  AIDS       Date:  2011-09-10       Impact factor: 4.177

3.  Effects of APOE ε4, age, and HIV on glial metabolites and cognitive deficits.

Authors:  Linda Chang; Caroline Jiang; Eric Cunningham; Steven Buchthal; Vanessa Douet; Marilou Andres; Thomas Ernst
Journal:  Neurology       Date:  2014-05-21       Impact factor: 9.910

4.  Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection.

Authors:  Andrew C Young; Constantin T Yiannoutsos; Manu Hegde; Evelyn Lee; Julia Peterson; Rudy Walter; Richard W Price; Dieter J Meyerhoff; Serena Spudich
Journal:  Neurology       Date:  2014-09-26       Impact factor: 9.910

5.  Impact of minocycline on cerebrospinal fluid markers of oxidative stress, neuronal injury, and inflammation in HIV-seropositive individuals with cognitive impairment.

Authors:  Ned Sacktor; Sachiko Miyahara; Scott Evans; Giovanni Schifitto; Bruce Cohen; Norman Haughey; Julia L Drewes; David Graham; M Christine Zink; Caroline Anderson; Avindra Nath; Carlos A Pardo; Sean McCarthy; Lara Hosey; David Clifford
Journal:  J Neurovirol       Date:  2014-11-07       Impact factor: 2.643

6.  Cathepsin B and cystatin B in HIV-seropositive women are associated with infection and HIV-1-associated neurocognitive disorders.

Authors:  Yisel Cantres-Rosario; Marines Plaud-Valentín; Yamil Gerena; Richard L Skolasky; Valerie Wojna; Loyda M Meléndez
Journal:  AIDS       Date:  2013-01-28       Impact factor: 4.177

Review 7.  Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain.

Authors:  Linda Chang; Sody M Munsaka; Stephanie Kraft-Terry; Thomas Ernst
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-12       Impact factor: 4.147

Review 8.  Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorder.

Authors:  Andrew J Levine; Stella E Panos; Steve Horvath
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

9.  Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China.

Authors:  Lin Yuan; Luxin Qiao; Feili Wei; Jiming Yin; Lifeng Liu; Yunxia Ji; Davey Smith; Ning Li; Dexi Chen
Journal:  J Neurovirol       Date:  2013-02-07       Impact factor: 2.643

10.  Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy.

Authors:  Assawin Gongvatana; Jaroslaw Harezlak; Steven Buchthal; Eric Daar; Giovanni Schifitto; Thomas Campbell; Michael Taylor; Elyse Singer; Jeffrey Algers; Jianhui Zhong; Mark Brown; Deborah McMahon; Yuen T So; Deming Mi; Robert Heaton; Kevin Robertson; Constantin Yiannoutsos; Ronald A Cohen; Bradford Navia
Journal:  J Neurovirol       Date:  2013-04-24       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.